⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RIGL News
Rigel Pharmaceuticals Inc. (New)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com
RIGL
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Form 8-K
sec.gov
RIGL
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer
prnewswire.com
RIGL
Form 8-K
sec.gov
RIGL
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
prnewswire.com
RIGL
ARVN
PFE
Altesa BioSciences Appoints Brett Haumann, MBBCh, MBA, to its Board of Directors and Gwen Skloot, MD, ATSF, as Senior Vice President for Clinical Development
prnewswire.com
RIGL
GSK
Knight Therapeutics Announces Launch of TAVALISSE® in Mexico
globenewswire.com
RIGL
Rigel to Present at the Jefferies Global Healthcare Conference
prnewswire.com
RIGL
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
prnewswire.com
RIGL